Sun Pharma announces positive Phase 4 data results in dry eye disease
Author(s): David Hutton Key Takeaways Cyclosporine ophthalmic solution 0.09% significantly improves dry eye disease symptoms in patients inadequately controlled on Restasis. The Phase 4 study showed sustained improvements in corneal…